Co-Founder, and Managing Director at RA Capital Management
Andrew Levin is a Co-Founder of Imbria Pharmaceuticals. Since joining RA Capital Management in 2015, Dr. Levin has been spearheading drug discovery efforts that have led to the formation of several companies and is also a Managing Director on the Investment Team. Prior to joining RA Capital, he was a Vice President at H.I.G. BioVentures and previously served as the Director of Pharmaceutical Sciences at the Clinton Health Access Initiative. Dr. Levin holds a BSE in Mechanical Engineering from Princeton University, a PhD in Biomedical Engineering from the Massachusetts Institute of Technology, and an MD from Harvard Medical School.